Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Myelogenous Leukemia in Chronic Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003406
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Cancer Treatment Centers of America 30
Testing effectiveness (Phase 2)Looking for participantsNCT03852407
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Who this might be right for
Acute Myeloid Leukemia in RemissionMyelodysplastic SyndromesChronic Myeloid Leukemia in Remission+7 more
University of Liege 114
Testing effectiveness (Phase 2)Looking for participantsNCT04838041
What this trial is testing

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia
Medical College of Wisconsin 51
Early research (Phase 1)Active Not RecruitingNCT04041050
What this trial is testing

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Who this might be right for
Myeloproliferative Neoplasm
AbbVie 85
Early research (Phase 1)Study completedNCT00854646
What this trial is testing

Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelocytic Leukemia+2 more
Traws Pharma, Inc. 22
Early research (Phase 1)Not Yet RecruitingNCT06530810
What this trial is testing

Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)

Who this might be right for
Chronic Myelogenous LeukemiaCML Chronic PhaseCML Accelerated Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd. 100
Testing effectiveness (Phase 2)Ended earlyNCT00451035
What this trial is testing

Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia in Chronic Phase
Novartis Pharmaceuticals 29
Early research (Phase 1)Active Not RecruitingNCT03560752
What this trial is testing

CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 34
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT01570868
What this trial is testing

Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT02689440
What this trial is testing

Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 155
Testing effectiveness (Phase 2)Study completedNCT00481052
What this trial is testing

Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 74
Testing effectiveness (Phase 2)Ended earlyNCT03593915
What this trial is testing

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Who this might be right for
Myelodysplastic Syndromes (MDS)
Sumitomo Pharma America, Inc. 20
Testing effectiveness (Phase 2)UnknownNCT03348033
What this trial is testing

Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Hospital de Clinicas de Porto Alegre 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03906292
What this trial is testing

Frontline Asciminib Combination in Chronic Phase CML

Who this might be right for
Chronic Myeloid Leukemia
University of Jena 125
Early research (Phase 1)Active Not RecruitingNCT04980404
What this trial is testing

Inqovi Maintenance Therapy in Myeloid Neoplasms

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaStem Cell Leukemia
Massachusetts General Hospital 22
Early research (Phase 1)Study completedNCT01677780
What this trial is testing

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Who this might be right for
Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute
Hoffmann-La Roche 11
Testing effectiveness (Phase 2)Study completedNCT00027924
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00118196
What this trial is testing

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Medical University of South Carolina 1
Early research (Phase 1)Study completedNCT00003079
What this trial is testing

Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Virginia Commonwealth University 30
Next Page